|
1
|
Florencio-Silva R, Sasso GR, Sasso-Cerri
E, Simões MJ and Cerri PS: Biology of bone tissue: Structure,
function, and factors that influence bone cells. Biomed Res Int.
2015:4217462015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lee HR, Yang SJ, Choi HK, Kim JA and Oh
IH: The chromatin remodeling complex CHD1 regulates the primitive
state of mesenchymal stromal cells to control their stem cell
supporting activity. Stem Cells Dev. 30:363–373. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schini M, Vilaca T, Gossiel F, Salam S and
Eastell R: Bone turnover markers: Basic biology to clinical
applications. Endocr Rev. 44:417–473. 2023. View Article : Google Scholar :
|
|
4
|
Hadjidakis DJ and Androulakis II: Bone
remodeling. Ann N Y Acad Sci. 1092:385–396. 2006. View Article : Google Scholar
|
|
5
|
Liang J, Yi Q, Liu Y, Li J, Yang Z and Sun
W and Sun W: Recent advances of m6A methylation in skeletal system
disease. J Transl Med. 22:1532024. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lane NE: Epidemiology, etiology, and
diagnosis of osteoporosis. Am J Obstet Gynecol. 194(2 Suppl):
S3–S11. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stark Z and Savarirayan R: Osteopetrosis.
Orphanet J Rare Dis. 4:52009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zheng J, Yao Z, Xue L, Wang D and Tan Z:
The role of immune cells in modulating chronic inflammation and
osteonecrosis. Front Immunol. 13:10642452022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Glyn-Jones S, Palmer AJ, Agricola R, Price
AJ, Vincent TL, Weinans H and Carr AJ: Osteoarthritis. Lancet.
386:376–387. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Choi JH and Ro JY: The 2020 WHO
classification of tumors of bone: An updated review. Adv Anat
Pathol. 28:119–138. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Park-Min KH: Epigenetic regulation of bone
cells. Connect Tissue Res. 58:76–89. 2017. View Article : Google Scholar :
|
|
12
|
Zhang Y, Wang Q, Xue H, Guo Y, Wei S, Li
F, Gong L, Pan W and Jiang P: Epigenetic regulation of autophagy in
bone metabolism. Function (Oxf). 5:zqae0042024. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sikora M, Marycz K and Smieszek A: Small
and Long Non-coding RNAs as functional regulators of bone
homeostasis, acting alone or cooperatively. Mol Ther Nucleic Acids.
21:792–803. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Du J, Liu Y, Wu X, Sun J, Shi J, Zhang H,
Zheng A, Zhou M and Jiang X: BRD9-mediated chromatin remodeling
suppresses osteoclastogenesis through negative feedback mechanism.
Nat Commun. 14:14132023. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Busby T, Chen Y, Godfrey TC, Rehan M,
Wildman BJ, Smith CM and Hassan Q: Baf45a mediated chromatin
remodeling promotes transcriptional activation for osteogenesis and
odontogenesis. Front Endocrinol (Lausanne). 12:7633922022.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang Y, Sun H, Huang F, Chen Y, Ding X,
Zhou C, Wu Y, Zhang Q, Ma X, Wang J, et al: The chromatin
remodeling factor Arid1a cooperates with Jun/Fos to promote
osteoclastogenesis by epigenetically upregulating Siglec15
expression. J Bone Miner Res. 39:775–790. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wei W, Tang X, Jiang N, Ni C, He H, Sun S,
Yu M, Yu C, Qiu M, Yan D, et al: Chromatin remodeler Znhit1
controls bone morphogenetic protein signaling in embryonic lung
tissue branching. J Biol Chem. 298:1024902022. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xue Y, Morris JL, Yang K, Fu Z, Zhu X,
Johnson F, Meehan B, Witkowski L, Yasmeen A, Golenar T, et al:
SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by
restricting IP3R3-mediated Ca(2+) flux to mitochondria. Nat Commun.
12:54042021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bosch PJ, Fuller LC and Weiner JA: A
critical role for the nuclear protein Akirin2 in the formation of
mammalian muscle in vivo. Genesis. 57:e232862019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gamarra N and Narlikar GJ; Collaboration
through chromatin: motors of transcription and chromatin structure.
J Mol Biol. 433:1668762021. View Article : Google Scholar
|
|
21
|
El Hadidy N and Uversky VN: Intrinsic
disorder of the BAF complex: Roles in chromatin remodeling and
disease development. Int J Mol Sci. 20:52602019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Clapier CR and Cairns BR: The biology of
chromatin remodeling complexes. Annu Rev Biochem. 78:273–304. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fröb F and Wegner M: The role of chromatin
remodeling complexes in Schwann cell development. Glia.
68:1596–1603. 2020. View Article : Google Scholar
|
|
24
|
Han Y, Reyes AA, Malik S and He Y: Cryo-EM
structure of SWI/SNF complex bound to a nucleosome. Nature.
579:452–455. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vary JC Jr, Gangaraju VK, Qin J, Landel
CC, Kooperberg C, Bartholomew B and Tsukiyama T: Yeast Isw1p forms
two separable complexes in vivo. Mol Cell Biol. 23:80–91. 2003.
View Article : Google Scholar
|
|
26
|
Reyes AA, Marcum RD and He Y: Structure
and function of chromatin remodelers. J Mol Biol. 433:1669292021.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nacev BA, Jones KB, Intlekofer AM, Yu JSE,
Allis CD, Tap WD, Ladanyi M and Nielsen TO: The epigenomics of
sarcoma. Nat Rev Cancer. 20:608–623. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Du W, Guo D and Du W: ATP-Dependent
chromatin remodeling complex in the lineage specification of
mesenchymal stem cells. Stem Cells Int. 2020:88397032020.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wojcik J and Cooper K: Epigenetic
alterations in bone and soft tissue tumors. Adv Anat Pathol.
24:362–371. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chakraborty S, Sinha S and Sengupta A:
Emerging trends in chromatin remodeler plasticity in mesenchymal
stromal cell function. FASEB J. 35:e212342021. View Article : Google Scholar
|
|
31
|
Kouzarides T: Chromatin modifications and
their function. Cell. 128:693–705. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Clapier CR, Iwasa J, Cairns BR and
Peterson CL: Mechanisms of action and regulation of ATP-dependent
chromatin-remodelling complexes. Nat Rev Mol Cell Biol. 18:407–422.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tyagi M, Imam N, Verma K and Patel AK:
Chromatin remodelers: We are the drivers! Nucleus. 7:388–404. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li Y, Gong H, Wang P, Zhu Y, Peng H, Cui
Y, Li H, Liu J and Wang Z: The emerging role of ISWI chromatin
remodeling complexes in cancer. J Exp Clin Cancer Res. 40:3462021.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Centore RC, Sandoval GJ, Soares LMM,
Kadoch C and Chan HM: Mammalian SWI/SNF chromatin remodeling
complexes: Emerging mechanisms and therapeutic strategies. Trends
Genet. 36:936–950. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Willhoft O and Wigley DB: INO80 and SWR1
complexes: The non-identical twins of chromatin remodelling. Curr
Opin Struct Biol. 61:50–58. 2020. View Article : Google Scholar :
|
|
37
|
Pulice JL and Kadoch C: Composition and
function of mammalian SWI/SNF chromatin remodeling complexes in
human disease. Cold Spring Harb Symp Quant Biol. 81:53–60. 2016.
View Article : Google Scholar
|
|
38
|
Judd J, Duarte FM and Lis JT: Pioneer-like
factor GAF cooperates with PBAP (SWI/SNF) and NURF (ISWI) to
regulate transcription. Genes Dev. 35:147–156. 2021. View Article : Google Scholar :
|
|
39
|
Poli J, Gasser SM and Papamichos-Chronakis
M: The INO80 remodeller in transcription, replication and repair.
Philos Trans R Soc Lond B Biol Sci. 372:201602902017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Trujillo JT, Long J, Aboelnour E, Ogas J
and Wisecaver JH: CHD Chromatin Remodeling Protein Diversification
Yields Novel Clades and Domains Absent in Classic Model Organisms.
Genome Biol Evol. 14:evac0662022. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Iyer J, Gentry LK, Bergwell M, Smith A,
Guagliardo S, Kropp PA, Sankaralingam P, Liu Y, Spooner E, Bowerman
B and O'Connell KF: The chromatin remodeling protein CHD-1 and the
EFL-1/DPL-1 transcription factor cooperatively down regulate CDK-2
to control SAS-6 levels and centriole number. PLoS Genet.
18:e10097992022. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ebbert R, Birkmann A and Schüller HJ: The
product of the SNF2/SWI2 paralogue INO80 of Saccharomyces
cerevisiae required for efficient expression of various yeast
structural genes is part of a high-molecular-weight protein
complex. Mol Microbiol. 32:741–751. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
van Attikum H, Fritsch O and Gasser SM:
Distinct roles for SWR1 and INO80 chromatin remodeling complexes at
chromosomal double-strand breaks. EMBO J. 26:4113–4125. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Conaway RC and Conaway JW: The INO80
chromatin remodeling complex in transcription, replication and
repair. Trends Biochem Sci. 34:71–77. 2009. View Article : Google Scholar
|
|
45
|
Saha A, Wittmeyer J and Cairns BR:
Mechanisms for nucleosome movement by ATP-dependent chromatin
remodeling complexes. Results Probl Cell Differ. 41:127–148. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Barisic D, Stadler MB, Iurlaro M and
Schübeler D: Mammalian ISWI and SWI/SNF selectively mediate binding
of distinct transcription factors. Nature. 569:136–140. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wang Y, He L, Du Y, Zhu P, Huang G, Luo J,
Yan X, Ye B, Li C, Xia P, et al: The long noncoding RNA lncTCF7
promotes self-renewal of human liver cancer stem cells through
activation of Wnt signaling. Cell Stem Cell. 16:413–425. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Tang Y, Wang J, Lian Y, Fan C, Zhang P, Wu
Y, Li X, Xiong F, Li X, Li G, et al: Linking long non-coding RNAs
and SWI/SNF complexes to chromatin remodeling in cancer. Mol
Cancer. 16:422017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Patty BJ and Hainer SJ: Non-Coding RNAs
and nucleosome remodeling complexes: An intricate regulatory
relationship. Biology (Basel). 9:2132020.PubMed/NCBI
|
|
50
|
Han P, Li W, Lin CH, Yang J, Shang C,
Nuernberg ST, Jin KK, Xu W, Lin CY, Lin CJ, et al: A long noncoding
RNA protects the heart from pathological hypertrophy. Nature.
514:102–106. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Atala A: Re: The long noncoding RNA
SChLAP1 promotes aggressive prostate cancer and antagonizes the
SWI/SNF complex. J Urol. 192:6132014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Yang Z, Mameri A, Cattoglio C, Lachance C,
Florez Ariza AJ, Luo J, Humbert J, Sudarshan D, Banerjea A, Galloy
M, et al: Structural insights into the human NuA4/TIP60
acetyltransferase and chromatin remodeling complex. Science.
385:eadl58162024. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Tallant C, Valentini E, Fedorov O,
Overvoorde L, Ferguson FM, Filippakopoulos P, Svergun DI, Knapp S
and Ciulli A: Molecular basis of histone tail recognition by human
TIP5 PHD finger and bromodomain of the chromatin remodeling complex
NoRC. Structure. 23:80–92. 2015. View Article : Google Scholar :
|
|
54
|
Charles GM, Chen C, Shih SC, Collins SR,
Beltrao P, Zhang X, Sharma T, Tan S, Burlingame AL, Krogan NJ, et
al: Site-specific acetylation mark on an essential
chromatin-remodeling complex promotes resistance to replication
stress. Proc Natl Acad Sci USA. 108:10620–10625. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Sala A, La Rocca G, Burgio G, Kotova E, Di
Gesù D, Collesano M, Ingrassia AM, Tulin AV and Corona DF: The
nucleosome-remodeling ATPase ISWI is regulated by
poly-ADP-ribosylation. PLoS Biol. 6:e2522008. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Bure IV and Nemtsova MV: Mutual regulation
of ncRNAs and chromatin remodeling complexes in normal and
pathological conditions. Int J Mol Sci. 24:78482023. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Young DW, Pratap J, Javed A, Weiner B,
Ohkawa Y, van Wijnen A, Montecino M, Stein GS, Stein JL, Imbalzano
AN and Lian JB: SWI/SNF chromatin remodeling complex is obligatory
for BMP2-induced, Runx2-dependent skeletal gene expression that
controls osteoblast differentiation. J Cell Biochem. 94:720–730.
2005. View Article : Google Scholar
|
|
58
|
Kuhn NZ and Tuan RS: Regulation of
stemness and stem cell niche of mesenchymal stem cells:
Implications in tumorigenesis and metastasis. J Cell Physiol.
222:268–277. 2010. View Article : Google Scholar
|
|
59
|
Im GI and Shin KJ: Epigenetic approaches
to regeneration of bone and cartilage from stem cells. Expert Opin
Biol Ther. 15:181–193. 2015. View Article : Google Scholar
|
|
60
|
Flowers S, Nagl NG Jr, Beck GR Jr and
Moran E: Antagonistic roles for BRM and BRG1 SWI/SNF complexes in
differentiation. J Biol Chem. 284:10067–10075. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Xu Y, Zhang J and Chen X: The activity of
p53 is differentially regulated by Brm- and Brg1-containing SWI/SNF
chromatin remodeling complexes. J Biol Chem. 282:37429–37435. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Moran A, Hoyt A, Sedani A, Granger C,
Saigh S, Blonska M, Zhao-Ju L, Conway SA, Pretell J, Brown J and
Galoian K: Proline-rich polypeptide-1 decreases cancer stem cell
population by targeting BAFF chromatin-remodeling complexes in
human chondrosarcoma JJ012 cells. Oncol Rep. 44:393–403. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Kidder BL, Palmer S and Knott JG:
SWI/SNF-Brg1 regulates self-renewal and occupies core
pluripotency-related genes in embryonic stem cells. Stem Cells.
27:317–328. 2009. View Article : Google Scholar
|
|
64
|
Nguyen KH, Xu F, Flowers S, Williams EA,
Fritton JC and Moran E: SWI/SNF-mediated lineage determination in
mesenchymal stem cells confers resistance to osteoporosis. Stem
Cells. 33:3028–3038. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Kitagawa T, Kobayashi D, Baron B, Okita H,
Miyamoto T, Takai R, Paudel D, Ohta T, Asaoka Y, Tokunaga M, et al:
AT-hook DNA-binding motif-containing protein one knockdown
downregulates EWS-FLI1 transcriptional activity in Ewing's sarcoma
cells. PLoS One. 17:e02690772022. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Wang X, Lee RS, Alver BH, Haswell JR, Wang
S, Mieczkowski J, Drier Y, Gillespie SM, Archer TC, Wu JN, et al:
SMARCB1-mediated SWI/SNF complex function is essential for enhancer
regulation. Nat Genet. 49:289–295. 2017. View Article : Google Scholar :
|
|
67
|
Nakayama RT, Pulice JL, Valencia AM,
McBride MJ, McKenzie ZM, Gillespie MA, Ku WL, Teng M, Cui K,
Williams RT, et al: SMARCB1 is required for widespread BAF
complex-mediated activation of enhancers and bivalent promoters.
Nat Genet. 49:1613–1623. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Zhang H, Wang X, Li J, Shi R and Ye Y: BAF
Complex in embryonic stem cells and early embryonic development.
Stem Cells Int. 2021:66688662021. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Antonelli M, Raso A, Mascelli S, Gessi M,
Nozza P, Coli A, Gardiman MP, Arcella A, Massimino M, Buttarelli FR
and Giangaspero F: SMARCB1/INI1 involvement in pediatric chordoma:
A mutational and immunohistochemical analysis. Am J Surg Pathol.
41:56–61. 2017. View Article : Google Scholar
|
|
70
|
Zhang X, Li B, Li W, Ma L, Zheng D, Li L,
Yang W, Chu M, Chen W, Mailman RB, et al: Transcriptional
repression by the BRG1-SWI/SNF complex affects the pluripotency of
human embryonic stem cells. Stem Cell Reports. 3:460–474. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Gatchalian J, Malik S, Ho J, Lee DS, Kelso
TWR, Shokhirev MN, Dixon JR and Hargreaves DC: A non-canonical
BRD9-containing BAF chromatin remodeling complex regulates naive
pluripotency in mouse embryonic stem cells. Nat Commun. 9:51392018.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Wang X, Song C, Ye Y, Gu Y, Li X, Chen P,
Leng D, Xiao J, Wu H, Xie S, et al: BRD9-mediated control of the
TGF-β/Activin/Nodal pathway regulates self-renewal and
differentiation of human embryonic stem cells and progression of
cancer cells. Nucleic Acids Res. 51:11634–11651. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Sevinç K, Sevinç GG, Cavga AD, Philpott M,
Kelekçi S, Can H, Cribbs AP, Yıldız AB, Yılmaz A, Ayar ES, et al:
BRD9-containing non-canonical BAF complex maintains somatic cell
transcriptome and acts as a barrier to human reprogramming. Stem
Cell Reports. 17:2629–2642. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Gaspar-Maia A, Alajem A, Polesso F,
Sridharan R, Mason MJ, Heidersbach A, Ramalho-Santos J, McManus MT,
Plath K, Meshorer E and Ramalho-Santos M: Chd1 regulates open
chromatin and pluripotency of embryonic stem cells. Nature.
460:863–868. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Baumgart SJ, Najafova Z, Hossan T, Xie W,
Nagarajan S, Kari V, Ditzel N, Kassem M and Johnsen SA: CHD1
regulates cell fate determination by activation of
differentiation-induced genes. Nucleic Acids Res. 45:7722–7735.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Bulut-Karslioglu A, Jin H, Kim YK, Cho B,
Guzman-Ayala M, Williamson AJK, Hejna M, Stötzel M, Whetton AD,
Song JS and Ramalho-Santos M: Chd1 protects genome integrity at
promoters to sustain hypertranscription in embryonic stem cells.
Nat Commun. 12:48592021. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Caplan AI: Mesenchymal stem cells. J
Orthop Res. 9:641–650. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Benayahu D, Shacham N and Shur I: Insights
on the functional role of chromatin remodelers in osteogenic cells.
Crit Rev Eukaryot Gene Expr. 17:103–113. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Suzuki S, Nozawa Y, Tsukamoto S, Kaneko T,
Manabe I, Imai H and Minami N: CHD1 acts via the Hmgpi pathway to
regulate mouse early embryogenesis. Development. 142:2375–2384.
2015.PubMed/NCBI
|
|
80
|
Liu C, Kang N, Guo Y and Gong P: Advances
in chromodomain helicase DNA-binding (CHD) proteins regulating stem
cell differentiation and human diseases. Front Cell Dev Biol.
9:7102032021. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Wan M, Liang J, Xiong Y, Shi F, Zhang Y,
Lu W, He Q, Yang D, Chen R, Liu D, et al: The trithorax group
protein Ash2l is essential for pluripotency and maintaining open
chromatin in embryonic stem cells. J Biol Chem. 288:5039–5048.
2013. View Article : Google Scholar :
|
|
82
|
Yang P, Oldfield A, Kim T, Yang A, Yang
JYH and Ho JWK: Integrative analysis identifies co-dependent gene
expression regulation of BRG1 and CHD7 at distal regulatory sites
in embryonic stem cells. Bioinformatics. 33:1916–1920. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Malla S, Martinez-Gamero C, Kumari K,
Achour C, Mermelekas G, Martinez-Delgado D, Coego A, Guallar D,
Roman AC and Aguilo F: Cooperative role of LSD1 and CHD7 in
regulating differentiation of mouse embryonic stem cells. Sci Rep.
14:284952024. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Chen Y, Wang M, Chen D, Wang J and Kang N:
Chromatin remodeling enzyme CHD7 is necessary for osteogenesis of
human mesenchymal stem cells. Biochem Biophys Res Commun.
478:1588–1593. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Yoo H, La H, Lee EJ, Choi HJ, Oh J, Thang
NX and Hong K: ATP-dependent chromatin remodeler CHD9 controls the
proliferation of embryonic stem cells in a cell culture
condition-dependent manner. Biology (Basel). 9:4282020.PubMed/NCBI
|
|
86
|
Salomon-Kent R, Marom R, John S, Dundr M,
Schiltz LR, Gutierrez J, Workman J, Benayahu D and Hager GL: New
face for chromatin-related mesenchymal modulator: n-CHD9 localizes
to nucleoli and interacts with ribosomal genes. J Cell Physiol.
230:2270–2280. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Wang L, Du Y, Ward JM, Shimbo T, Lackford
B, Zheng X, Miao YL, Zhou B, Han L, Fargo DC, et al: INO80
facilitates pluripotency gene activation in embryonic stem cell
self-renewal, reprogramming, and blastocyst development. Cell Stem
Cell. 14:575–591. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Furumatsu T and Ozaki T: Epigenetic
regulation in chondrogenesis. Acta Med Okayama. 64:155–161.
2010.PubMed/NCBI
|
|
89
|
Berendsen AD and Olsen BR: Bone
development. Bone. 80:14–18. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Mashtalir N, D'Avino AR, Michel BC, Luo J,
Pan J, Otto JE, Zullow HJ, McKenzie ZM, Kubiak RL, St Pierre R, et
al: Modular organization and assembly of SWI/SNF family chromatin
remodeling complexes. Cell. 175:1272–1288.e20. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
You S, Zhang Y, Xu J, Qian H, Wu S, Wu B,
Lu S, Sun Y and Zhang N: The role of BRG1 in antioxidant and redox
signaling. Oxid Med Cell Longev. 2020:60956732020. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Sun F, Chen Q, Yang S, Pan Q, Ma J, Wan Y,
Chang CH and Hong A: Remodeling of chromatin structure within the
promoter is important for bmp-2-induced fgfr3 expression. Nucleic
Acids Res. 37:3897–3911. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Sacitharan PK, Lwin S, Gharios GB and
Edwards JR: Spermidine restores dysregulated autophagy and
polyamine synthesis in aged and osteoarthritic chondrocytes via
EP300. Exp Mol Med. 50:1–10. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Chen Z, Lin CX, Song B, Li CC, Qiu JX, Li
SX, Lin SP, Luo WQ, Fu Y, Fang GB, et al: Spermidine activates RIP1
deubiquitination to inhibit TNF-α-induced NF-κB/p65 signaling
pathway in osteoarthritis. Cell Death Dis. 11:5032020. View Article : Google Scholar
|
|
95
|
Guo X, Feng X, Yang Y, Zhang H and Bai L:
Spermidine attenuates chondrocyte inflammation and cellular
pyroptosis through the AhR/NF-κB axis and the NLRP3/caspase-1/GSDMD
pathway. Front Immunol. 15:14627772024. View Article : Google Scholar
|
|
96
|
Mao X, Yan B, Chen H, Lai P and Ma J: BRG1
mediates protective ability of spermidine to ameliorate
osteoarthritic cartilage by Nrf2/KEAP1 and STAT3 signaling pathway.
Int Immunopharmacol. 122:1105932023. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Wei S, Pei J, von Mehren M, Abraham JA,
Patchefsky AS and Cooper HS: SMARCA2-NR4A3 is a novel fusion gene
of extraskeletal myxoid chondrosarcoma identified by RNA
next-generation sequencing. Genes Chromosomes Cancer. 60:709–712.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Schaefer IM and Hornick JL: SWI/SNF
complex-deficient soft tissue neoplasms: An update. Semin Diagn
Pathol. 38:222–231. 2021. View Article : Google Scholar :
|
|
99
|
Rekhi B and Vogel U: Utility of
characteristic 'Weak to Absent' INI1/SMARCB1/BAF47 expression in
diagnosis of synovial sarcomas. Apmis. 123:618–628. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Fanburg-Smith JC, Auerbach A, Marwaha JS,
Wang Z, Santi M, Judkins AR and Rushing EJ: Immunoprofile of
mesenchymal chondrosarcoma: Aberrant desmin and EMA expression,
retention of INI1, and negative estrogen receptor in 22
female-predominant central nervous system and musculoskeletal
cases. Ann Diagn Pathol. 14:8–14. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Kohashi K, Oda Y, Yamamoto H, Tamiya S,
Matono H, Iwamoto Y, Taguchi T and Tsuneyoshi M: Reduced expression
of SMARCB1/INI1 protein in synovial sarcoma. Mod Pathol.
23:981–990. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Shain AH and Pollack JR: The spectrum of
SWI/SNF mutations, ubiquitous in human cancers. PLoS One.
8:e551192013. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Kadoch C, Williams RT, Calarco JP, Miller
EL, Weber CM, Braun SM, Pulice JL, Chory EJ and Crabtree GR:
Dynamics of BAF-Polycomb complex opposition on heterochromatin in
normal and oncogenic states. Nat Genet. 49:213–222. 2017.
View Article : Google Scholar
|
|
104
|
Cheng Y, Shen Z, Gao Y, Chen F, Xu H, Mo
Q, Chu X, Peng CL, McKenzie TT, Palacios BE, et al: Phase
transition and remodeling complex assembly are important for
SS18-SSX oncogenic activity in synovial sarcomas. Nat Commun.
13:27242022. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
McBride MJ, Pulice JL, Beird HC, Ingram
DR, D'Avino AR, Shern JF, Charville GW, Hornick JL, Nakayama RT,
Garcia-Rivera EM, et al: The SS18-SSX fusion oncoprotein hijacks
BAF complex targeting and function to drive synovial sarcoma.
Cancer Cell. 33:1128–1141.e7. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Zhang N, Zhang Y, Chen Y, Qian H, Wu B, Lu
S, You S, Xu W, Zou Y, Huang X, et al: BAF155 promotes cardiac
hypertrophy and fibrosis through inhibition of WWP2-mediated PARP1
ubiquitination. Cell Discov. 9:462023. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Jeon S and Seong RH: Anteroposterior limb
skeletal patterning requires the bifunctional action of SWI/SNF
chromatin remodeling complex in hedgehog pathway. PLoS Genet.
12:e10059152016. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Ju C, Liu R, Zhang YW, Zhang Y, Zhou R,
Sun J, Lv XB and Zhang Z: Mesenchymal stem cell-associated lncRNA
in osteogenic differentiation. Biomed Pharmacother. 115:1089122019.
View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Peng Y, Jiang H and Zuo HD: Factors
affecting osteogenesis and chondrogenic differentiation of
mesenchymal stem cells in osteoarthritis. World J Stem Cells.
15:548–560. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Toosi S and Behravan J: Osteogenesis and
bone remodeling: A focus on growth factors and bioactive peptides.
Biofactors. 46:326–340. 2020. View Article : Google Scholar
|
|
111
|
Gou Y, Huang Y, Luo W, Li Y, Zhao P, Zhong
J, Dong X, Guo M, Li A, Hao A, et al: Adipose-derived mesenchymal
stem cells (MSCs) are a superior cell source for bone tissue
engineering. Bioact Mater. 34:51–63. 2023.
|
|
112
|
Sinha S, Biswas M, Chatterjee SS, Kumar S
and Sengupta A: Pbrm1 steers mesenchymal stromal cell osteolineage
differentiation by integrating PBAF-dependent chromatin remodeling
and BMP/TGF-β signaling. Cell Rep. 31:1075702020. View Article : Google Scholar
|
|
113
|
Mardinian K, Adashek JJ, Botta GP, Kato S
and Kurzrock R: SMARCA4: Implications of an altered
chromatin-remodeling gene for cancer development and therapy. Mol
Cancer Ther. 20:2341–2351. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Hojo H, Saito T, He X, Guo Q, Onodera S,
Azuma T, Koebis M, Nakao K, Aiba A, Seki M, et al: Runx2 regulates
chromatin accessibility to direct the osteoblast program at
neonatal stages. Cell Rep. 40:1113152022. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Nagl NG Jr, Patsialou A, Haines DS, Dallas
PB, Beck GR Jr and Moran E: The p270 (ARID1A/SMARCF1) subunit of
mammalian SWI/SNF-related complexes is essential for normal cell
cycle arrest. Cancer Res. 65:9236–9244. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Bailey S, Karsenty G, Gundberg C and
Vashishth D: Osteocalcin and osteopontin influence bone morphology
and mechanical properties. Ann N Y Acad Sci. 1409:79–84. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Komori T: Functions of osteocalcin in
bone, pancreas, testis, and muscle. Int J Mol Sci. 21:75132020.
View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Villagra A, Cruzat F, Carvallo L, Paredes
R, Olate J, van Wijnen AJ, Stein GS, Lian JB, Stein JL, Imbalzano
AN and Montecino M: Chromatin remodeling and transcriptional
activity of the bone-specific osteocalcin gene require
CCAAT/enhancer-binding protein beta-dependent recruitment of
SWI/SNF activity. J Biol Chem. 281:22695–22706. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Flowers S, Patel PJ, Gleicher S, Amer K,
Himelman E, Goel S and Moran E: p107-Dependent recruitment of
SWI/SNF to the alkaline phosphatase promoter during osteoblast
differentiation. Bone. 69:47–54. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Reyes JC, Barra J, Muchardt C, Camus A,
Babinet C and Yaniv M: Altered control of cellular proliferation in
the absence of mammalian brahma (SNF2alpha). EMBO J. 17:6979–6991.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Middeljans E, Wan X, Jansen PW, Sharma V,
Stunnenberg HG and Logie C: SS18 together with animal-specific
factors defines human BAF-type SWI/SNF complexes. PLoS One.
7:e338342012. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Godfrey TC, Wildman BJ, Javed A, Lengner
CJ and Hassan MQ: Epigenetic remodeling and modification to
preserve skeletogenesis in vivo. Connect Tissue Res. 59(supp1):
S52–S54. 2018. View Article : Google Scholar
|
|
123
|
Hasenfratz M, Mellert K, Marienfeld R, von
Baer A, Schultheiss M, Roitman PD, Aponte-Tinao LA, Lehner B,
Möller P, Mechtersheimer G and Barth TFE: Profiling of three
H3F3A-mutated and denosumab-treated giant cell tumors of bone
points to diverging pathways during progression and malignant
transformation. Sci Rep. 11:57092021. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Xu F, Flowers S and Moran E: Essential
role of ARID2 protein-containing SWI/SNF complex in tissue-specific
gene expression. J Biol Chem. 287:5033–5041. 2012. View Article : Google Scholar :
|
|
125
|
Wilsker D, Patsialou A, Dallas PB and
Moran E: ARID proteins: A diverse family of DNA binding proteins
implicated in the control of cell growth, differentiation, and
development. Cell Growth Differ. 13:95–106. 2002.PubMed/NCBI
|
|
126
|
Hu K, Liao D, Wu W, Han AJ, Shi HJ, Wang
F, Wang X, Zhong L, Duan T, Wu Y, et al: Targeting the
anaphase-promoting complex/cyclosome (APC/C)-bromodomain containing
7 (BRD7) pathway for human osteosarcoma. Oncotarget. 5:3088–3100.
2014. View Article : Google Scholar :
|
|
127
|
Liu C, Xiong Q, Li Q, Lin W, Jiang S,
Zhang D, Wang Y, Duan X, Gong P and Kang N: CHD7 regulates bone-fat
balance by suppressing PPAR-γ signaling. Nat Commun. 13:19892022.
View Article : Google Scholar
|
|
128
|
Takada I, Yogiashi Y and Kato S: Signaling
crosstalk between PPARγ and BMP2 in mesenchymal stem cells. PPAR
Res. 2012:6071412012. View Article : Google Scholar
|
|
129
|
Schnetz MP, Bartels CF, Shastri K,
Balasubramanian D, Zentner GE, Balaji R, Zhang X, Song L, Wang Z,
Laframboise T, et al: Genomic distribution of CHD7 on chromatin
tracks H3K4 methylation patterns. Genome Res. 19:590–601. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Newton AH and Pask AJ: CHD9 upregulates
RUNX2 and has a potential role in skeletal evolution. BMC Mol Cell
Biol. 21:272020. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Zhou C, Zou J, Zou S and Li X: INO80 is
required for osteogenic differentiation of human mesenchymal stem
cells. Sci Rep. 6:359242016. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Anwar A, Sapra L, Gupta N, Ojha RP, Verma
B and Srivastava RK: Fine-tuning osteoclastogenesis: An insight
into the cellular and molecular regulation of osteoclastogenesis. J
Cell Physiol. 238:1431–1464. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Du J, Liu Y, Sun J, Yao E, Xu J, Wu X, Xu
L, Zhou M, Yang G and Jiang X: ARID1A safeguards the canalization
of the cell fate decision during osteoclastogenesis. Nat Commun.
15:59942024. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Urban W, Krzystańska D, Piekarz M, Nazar J
and Jankowska A: Osteosarcoma's genetic landscape painted by genes'
mutations. Acta Biochim Pol. 70:671–678. 2023.PubMed/NCBI
|
|
135
|
Gaeta R, Morelli M, Lessi F, Mazzanti CM,
Menicagli M, Capanna R, Andreani L, Coccoli L, Aretini P and
Franchi A: Identification of new potential prognostic and
predictive markers in high-grade osteosarcoma using whole exome
sequencing. Int J Mol Sci. 24:100862023. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Tuckermann J and Adams RH: The
endothelium-bone axis in development, homeostasis and bone and
joint disease. Nat Rev Rheumatol. 17:608–620. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Bixel MG, Sivaraj KK, Timmen M,
Mohanakrishnan V, Aravamudhan A, Adams S, Koh BI, Jeong HW, Kruse
K, Stange R and Adams RH: Angiogenesis is uncoupled from
osteogenesis during calvarial bone regeneration. Nat Commun.
15:45752024. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Duan X, Murata Y, Liu Y, Nicolae C, Olsen
BR and Berendsen AD: Vegfa regulates perichondrial vascularity and
osteoblast differentiation in bone development. Development.
142:1984–1991. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Sena JA, Wang L and Hu CJ: BRG1 and BRM
chromatin-remodeling complexes regulate the hypoxia response by
acting as coactivators for a subset of hypoxia-inducible
transcription factor target genes. Mol Cell Biol. 33:3849–3863.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Wang F, Zhang R, Beischlag TV, Muchardt C,
Yaniv M and Hankinson O: Roles of Brahma and Brahma/SWI2-related
gene 1 in hypoxic induction of the erythropoietin gene. J Biol
Chem. 279:46733–46741. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Wang Y, Chen Y, Bao L, Zhang B, Wang JE,
Kumar A, Xing C, Wang Y and Luo W: CHD4 promotes breast cancer
progression as a coactivator of hypoxia-inducible factors. Cancer
Res. 80:3880–3891. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Collins JM, Lang A, Parisi C, Moharrer Y,
Nijsure MP, Thomas Kim JH, Ahmed S, Szeto GL, Qin L, Gottardi R, et
al: YAP and TAZ couple osteoblast precursor mobilization to
angiogenesis and mechanoregulation in murine bone development. Dev
Cell. 59:211–227.e5. 2024. View Article : Google Scholar :
|
|
143
|
Griffin CT, Brennan J and Magnuson T: The
chromatin-remodeling enzyme BRG1 plays an essential role in
primitive erythropoiesis and vascular development. Development.
135:493–500. 2008. View Article : Google Scholar
|
|
144
|
Davis RB, Curtis CD and Griffin CT: BRG1
promotes COUP-TFII expression and venous specification during
embryonic vascular development. Development. 140:1272–1281. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Ingram KG, Curtis CD, Silasi-Mansat R,
Lupu F and Griffin CT: The NuRD chromatin-remodeling enzyme CHD4
promotes embryonic vascular integrity by transcriptionally
regulating extracellular matrix proteolysis. PLoS Genet.
9:e10040312013. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Forriol F and Shapiro F: Bone development:
interaction of molecular components and biophysical forces. Clin
Orthop Relat Res. 432:14–33. 2005. View Article : Google Scholar
|
|
147
|
Komori T: Cell death in chondrocytes,
osteoblasts, and osteocytes. Int J Mol Sci. 17:20452016. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Grandy R, Sepulveda H, Aguilar R, Pihan P,
Henriquez B, Olate J and Montecino M: The Ric-8B gene is highly
expressed in proliferating preosteoblastic cells and downregulated
during osteoblast differentiation in a SWI/SNF- and
C/EBPbeta-mediated manner. Mol Cell Biol. 31:2997–3008. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Zhang M, Guo T, Pei F, Feng J, Jing J, Xu
J, Yamada T, Ho TV, Du J, Sehgal P and Chai Y: ARID1B maintains
mesenchymal stem cell quiescence via inhibition of BCL11B-mediated
non-canonical activin signaling. Nat Commun. 15:46142024.
View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Ho L, Ronan JL, Wu J, Staahl BT, Chen L,
Kuo A, Lessard J, Nesvizhskii AI, Ranish J and Crabtree GR: An
embryonic stem cell chromatin remodeling complex, esBAF, is
essential for embryonic stem cell self-renewal and pluripotency.
Proc Natl Acad Sci USA. 106:5181–5186. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Schaniel C, Ang YS, Ratnakumar K, Cormier
C, James T, Bernstein E, Lemischka IR and Paddison PJ:
Smarcc1/Baf155 couples self-renewal gene repression with changes in
chromatin structure in mouse embryonic stem cells. Stem Cells.
27:2979–2991. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Yan Z, Wang Z, Sharova L, Sharov AA, Ling
C, Piao Y, Aiba K, Matoba R, Wang W and Ko MS: BAF250B-associated
SWI/SNF chromatin-remodeling complex is required to maintain
undifferentiated mouse embryonic stem cells. Stem Cells.
26:1155–1165. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Eleuteri B, Aranda S and Ernfors P: NoRC
Recruitment by H2A.X deposition at rRNA gene promoter limits
embryonic stem cell proliferation. Cell Rep. 23:1853–1866. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Li B, Lyu P, Tang J, Li J, Ouchi T, Fan Y,
Zhao Z and Li L: The potential role and therapeutic relevance of
cellular senescence in skeletal pathophysiology. J Gerontol A Biol
Sci Med Sci. 79:glae0372024. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Napolitano MA, Cipollaro M, Cascino A,
Melone MA, Giordano A and Galderisi U: Brg1 chromatin remodeling
factor is involved in cell growth arrest, apoptosis and senescence
of rat mesenchymal stem cells. J Cell Sci. 120(Pt 16): 2904–2911.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Alessio N, Squillaro T, Cipollaro M,
Bagella L, Giordano A and Galderisi U: The BRG1 ATPase of chromatin
remodeling complexes is involved in modulation of mesenchymal stem
cell senescence through RB-P53 pathways. Oncogene. 29:5452–5463.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Squillaro T, Severino V, Alessio N, Farina
A, Di Bernardo G, Cipollaro M, Peluso G, Chambery A and Galderisi
U: De-regulated expression of the BRG1 chromatin remodeling factor
in bone marrow mesenchymal stromal cells induces senescence
associated with the silencing of NANOG and changes in the levels of
chromatin proteins. Cell Cycle. 14:1315–1326. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Yuan J and Ofengeim D: A guide to cell
death pathways. Nat Rev Mol Cell Biol. 25:379–395. 2024. View Article : Google Scholar
|
|
159
|
Klochendler-Yeivin A, Fiette L, Barra J,
Muchardt C, Babinet C and Yaniv M: The murine SNF5/INI1 chromatin
remodeling factor is essential for embryonic development and tumor
suppression. EMBO Rep. 1:500–506. 2000. View Article : Google Scholar
|
|
160
|
Li S, Huang Z, Zhu Y, Yan J, Li J, Chen J,
Zhou J, Zhang Y, Chen W, Xu K and Ye W: Bromodomain-containing
protein 7 regulates matrix metabolism and apoptosis in human
nucleus pulposus cells through the BRD7-PI3K-YAP1 signaling axis.
Exp Cell Res. 405:1126582021. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Li Z, Cheng W, Gao K, Liang S, Ke L, Wang
M, Fan J, Li D, Zhang P, Xu Z and Li N: Pyroptosis: A spoiler of
peaceful coexistence between cells in degenerative bone and joint
diseases. J Adv Res. 71:227–262. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Chai S, Yang Y, Wei L, Cao Y, Ma J, Zheng
X, Teng J and Qin N: Luteolin rescues postmenopausal osteoporosis
elicited by OVX through alleviating osteoblast pyroptosis via
activating PI3K-AKT signaling. Phytomedicine. 128:1555162024.
View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Ruan H, Zhang H, Feng J, Luo H, Fu F, Yao
S, Zhou C, Zhang Z, Bian Y, Jin H, et al: Inhibition of
Caspase-1-mediated pyroptosis promotes osteogenic differentiation,
offering a therapeutic target for osteoporosis. Int
Immunopharmacol. 124(Pt B): 1109012023. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Deng Z, Zhang Y, Zhu Y, Zhu J, Li S, Huang
Z, Qin T, Wu J, Zhang C, Chen W, et al: BRD9 inhibition attenuates
matrix degradation and pyroptosis in nucleus pulposus by modulating
the NOX1/ROS/NF-κB axis. Inflammation. 46:1002–1021. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Wang J, Zhang Y, Cao J, Wang Y, Anwar N,
Zhang Z, Zhang D, Ma Y, Xiao Y, Xiao L and Wang X: The role of
autophagy in bone metabolism and clinical significance. Autophagy.
19:2409–2427. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Ren X, Xu J, Xue Q, Tong Y, Xu T, Wang J,
Yang T, Chen Y, Shi D and Li X: BRG1 enhances porcine iPSC
pluripotency through WNT/β-catenin and autophagy pathways.
Theriogenology. 215:10–23. 2024. View Article : Google Scholar
|
|
167
|
Yang C, Tian Y, Zhao F, Chen Z, Su P, Li Y
and Qian A: Bone microenvironment and osteosarcoma metastasis. Int
J Mol Sci. 21:69852020. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Urlić I, Jovičić MŠ, Ostojić K and Ivković
A: Cellular and genetic background of osteosarcoma. Curr Issues Mol
Biol. 45:4344–4358. 2023. View Article : Google Scholar
|
|
169
|
Hang JF and Chen PC: Parosteal
osteosarcoma. Arch Pathol Lab Med. 138:694–699. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Qiu YQ and Chen YL: Primary meningeal
osteoblastic osteosarcoma containing fibroblast osteosarcoma:
Clinicopathological analysis and literature review. Osteoporos Int.
32:1007–1012. 2021. View Article : Google Scholar
|
|
171
|
Guan Y, Zhang W, Mao Y and Li S:
Nanoparticles and bone microenvironment: A comprehensive review for
malignant bone tumor diagnosis and treatment. Mol Cancer.
23:2462024. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Basu Mallick A and Chawla SP: Giant cell
tumor of bone: An update. Curr Oncol Rep. 23:512021. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Corre I, Verrecchia F, Crenn V, Redini F
and Trichet V: The osteosarcoma microenvironment: A complex but
targetable ecosystem. Cells. 9:9762020. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Grünewald TGP, Cidre-Aranaz F, Surdez D,
Tomazou EM, de Álava E, Kovar H, Sorensen PH, Delattre O and
Dirksen U: Ewing sarcoma. Nat Rev Dis Primers. 4:52018. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Weber K, Damron TA, Frassica FJ and Sim
FH: Malignant bone tumors. Instr Course Lect. 57:673–688.
2008.PubMed/NCBI
|
|
176
|
Graca Marques J, Pavlovic B, Ngo QA, Pedot
G, Roemmele M, Volken L, Kisele S, Perbet R, Wachtel M and Schäfer
BW: The chromatin remodeler CHD4 sustains ewing sarcoma cell
survival by controlling global chromatin architecture. Cancer Res.
84:241–257. 2024. View Article : Google Scholar
|
|
177
|
Sohn EJ and Libich DS: Hijacking the BAF
complex: The mechanistic interplay of ARID1A and EWS::FLI1 in Ewing
sarcoma. Mol Oncol. 19:961–964. 2025. View Article : Google Scholar :
|
|
178
|
Selvanathan SP, Graham GT, Grego AR, Baker
TM, Hogg JR, Simpson M, Batish M, Crompton B, Stegmaier K, Tomazou
EM, et al: EWS-FLI1 modulated alternative splicing of ARID1A
reveals novel oncogenic function through the BAF complex. Nucleic
Acids Res. 47:9619–9636. 2019.PubMed/NCBI
|
|
179
|
Boulay G, Sandoval GJ, Riggi N, Iyer S,
Buisson R, Naigles B, Awad ME, Rengarajan S, Volorio A, McBride MJ,
et al: Cancer-specific retargeting of BAF complexes by a prion-like
domain. Cell. 171:163–178.e19. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Jayabal P, Zhou F, Lei X, Ma X, Blackman
B, Weintraub ST, Houghton PJ and Shiio Y: NELL2-cdc42 signaling
regulates BAF complexes and Ewing sarcoma cell growth. Cell Rep.
36:1092542021. View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Cyra M, Schulte M, Berthold R, Heinst L,
Jansen EP, Grünewald I, Elges S, Larsson O, Schliemann C,
Steinestel K, et al: SS18-SSX drives CREB activation in synovial
sarcoma. Cell Oncol (Dordr). 45:399–413. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Michel BC, D'Avino AR, Cassel SH,
Mashtalir N, McKenzie ZM, McBride MJ, Valencia AM, Zhou Q, Bocker
M, Soares LMM, et al: A non-canonical SWI/SNF complex is a
synthetic lethal target in cancers driven by BAF complex
perturbation. Nat Cell Biol. 20:1410–1420. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
183
|
Shih AR, Cote GM, Chebib I, Choy E,
DeLaney T, Deshpande V, Hornicek FJ, Miao R, Schwab JH, Nielsen GP
and Chen YL: Clinicopathologic characteristics of poorly
differentiated chordoma. Mod Pathol. 31:1237–1245. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Sergi CM: Commentary on: SMARCB1 as a
novel diagnostic and prognostic biomarker for osteosarcoma. Biosci
Rep. 42:BSR202200402022. View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Mobley BC, McKenney JK, Bangs CD, Callahan
K, Yeom KW, Schneppenheim R, Hayden MG, Cherry AM, Gokden M,
Edwards MS, et al: Loss of SMARCB1/INI1 expression in poorly
differentiated chordomas. Acta Neuropathol. 120:745–753. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Ding J, Yu C, Sui Y, Wang L, Yang Y, Wang
F, Yao H, Xing F, Liu H, Li Y, et al: The chromatin remodeling
protein INO80 contributes to the removal of H2A.Z at the
p53-binding site of the p21 gene in response to doxorubicin. FEBS
J. 285:3270–3285. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
187
|
Flowers S, Beck GR Jr and Moran E:
Transcriptional activation by pRB and its coordination with SWI/SNF
recruitment. Cancer Res. 70:8282–8287. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
188
|
Meisenberg C, Pinder SI, Hopkins SR,
Wooller SK, Benstead-Hume G, Pearl FMG, Jeggo PA and Downs JA:
Repression of transcription at DNA breaks requires cohesin
throughout interphase and prevents genome instability. Mol Cell.
73:212–223.e7. 2019. View Article : Google Scholar :
|
|
189
|
Ivanov AV, Peng H, Yurchenko V, Yap KL,
Negorev DG, Schultz DC, Psulkowski E, Fredericks WJ, White DE, Maul
GG, et al: PHD domain-mediated E3 ligase activity directs
intramolecular sumoylation of an adjacent bromodomain required for
gene silencing. Mol Cell. 28:823–837. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
190
|
Walhart TA, Vacca B, Hepperla AJ, Hamad
SH, Petrongelli J, Wang Y, McKean EL, Moksa M, Cao Q, Yip S, et al:
SMARCB1 loss in poorly differentiated chordomas drives tumor
progression. Am J Pathol. 193:456–473. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
191
|
Passeri T, Gutman T, Hamza A,
Adle-Biassette H, Girard E, Beaurepere R, Tariq Z, Mariani O,
Dahmani A, Bourneix C, et al: The mutational landscape of skull
base and spinal chordomas and the identification of potential
prognostic and theranostic biomarkers. J Neurosurg. 139:1270–1280.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
192
|
Wu X, Lin X, Chen Y, Kong W, Xu J and Yu
Z: Response of metastatic chordoma to the immune checkpoint
inhibitor pembrolizumab: A case report. Front Oncol. 10:5659452020.
View Article : Google Scholar
|
|
193
|
Wang L, Zehir A, Nafa K, Zhou N, Berger
MF, Casanova J, Sadowska J, Lu C, Allis CD, Gounder M, et al:
Genomic aberrations frequently alter chromatin regulatory genes in
chordoma. Genes Chromosomes Cancer. 55:591–600. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
194
|
Harlow ML, Chasse MH, Boguslawski EA,
Sorensen KM, Gedminas JM, Kitchen-Goosen SM, Rothbart SB, Taslim C,
Lessnick SL, Peck AS, et al: Trabectedin inhibits EWS-FLI1 and
evicts SWI/SNF from chromatin in a schedule-dependent manner. Clin
Cancer Res. 25:3417–3429. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
195
|
Livingston JA, Blay JY, Trent J, Valverde
C, Agulnik M, Gounder M, Le Cesne A, McKean M, Wagner MJ,
Stacchiotti S, et al: A phase I study of FHD-609, a
heterobifunctional degrader of bromodomain-containing protein 9, in
patients with advanced synovial sarcoma or SMARCB1-deficient
tumors. Clin Cancer Res. 31:628–638. 2025. View Article : Google Scholar
|
|
196
|
Dreier MR, Walia J and de la Serna IL:
Targeting SWI/SNF complexes in cancer: Pharmacological approaches
and implications. Epigenomes. 8:72024. View Article : Google Scholar : PubMed/NCBI
|
|
197
|
Gatchalian J, Liao J, Maxwell MB and
Hargreaves DC: Control of stimulus-dependent responses in
macrophages by SWI/SNF chromatin remodeling complexes. Trends
Immunol. 41:126–140. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
198
|
Li X, Ding D, Yao J, Zhou B, Shen T, Qi Y,
Ni T and Wei G: Chromatin remodeling factor BAZ1A regulates
cellular senescence in both cancer and normal cells. Life Sci.
229:225–232. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
199
|
Martel-Pelletier J, Barr AJ, Cicuttini FM,
Conaghan PG, Cooper C, Goldring MB, Goldring SR, Jones G, Teichtahl
AJ, Pelletier JP, et al: Osteoarthritis. Nat Rev Dis Primers.
2:160722016. View Article : Google Scholar : PubMed/NCBI
|
|
200
|
Wang D, Zhang Y, Zhang L, He D, Zhao L,
Miao Z, Cheng W, Zhu C, Zhu L, Zhang W, et al: IRF1 governs the
expression of SMARCC1 via the GCN5-SETD2 axis and actively engages
in the advancement of osteoarthritis. J Orthop Translat.
45:211–225. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
201
|
Qiu Y, Yao J, Li L, Xiao M, Meng J, Huang
X, Cai Y, Wen Z, Huang J, Zhu M, et al: Machine learning identifies
ferroptosis-related genes as potential diagnostic biomarkers for
osteoarthritis. Front Endocrinol (Lausanne). 14:11987632023.
View Article : Google Scholar : PubMed/NCBI
|
|
202
|
Devlin MJ and Rosen CJ: The bone-fat
interface: Basic and clinical implications of marrow adiposity.
Lancet Diabetes Endocrinol. 3:141–147. 2015. View Article : Google Scholar
|
|
203
|
Kuznia AL, Hernandez AK and Lee LU:
Adolescent idiopathic scoliosis: Common questions and answers. Am
Fam Physician. 101:19–23. 2020.PubMed/NCBI
|
|
204
|
Cheng JC, Castelein RM, Chu WC, Danielsson
AJ, Dobbs MB, Grivas TB, Gurnett CA, Luk KD, Moreau A, Newton PO,
et al: Adolescent idiopathic scoliosis. Nat Rev Dis Primers.
1:150302015. View Article : Google Scholar : PubMed/NCBI
|
|
205
|
Wu Z, Dai Z, Yuwen W, Liu Z, Qiu Y, Cheng
JC, Zhu Z and Xu L: Genetic variants of CHD7 are associated with
adolescent idiopathic scoliosis. Spine (Phila Pa 1976).
46:E618–E624. 2021. View Article : Google Scholar
|
|
206
|
Borysiak K, Janusz P, Andrusiewicz M,
Chmielewska M, Kozinoga M, Kotwicki T and Kotwicka M: CHD7 gene
polymorphisms in female patients with idiopathic scoliosis. BMC
Musculoskelet Disord. 21:182020. View Article : Google Scholar : PubMed/NCBI
|
|
207
|
Kulkarni S, Nagarajan P, Wall J, Donovan
DJ, Donell RL, Ligon AH, Venkatachalam S and Quade BJ: Disruption
of chromodomain helicase DNA binding protein 2 (CHD2) causes
scoliosis. Am J Med Genet A. 146A:1117–1127. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
208
|
Bonyadi M, Waldman SD, Liu D, Aubin JE,
Grynpas MD and Stanford WL: Mesenchymal progenitor self-renewal
deficiency leads to age-dependent osteoporosis in Sca-1/Ly-6A null
mice. Proc Natl Acad Sci USA. 100:5840–5845. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
209
|
Yu W, Wang HL, Zhang J and Yin C: The
effects of epigenetic modifications on bone remodeling in
age-related osteoporosis. Connect Tissue Res. 64:105–116. 2023.
View Article : Google Scholar
|
|
210
|
Li C, Pan H, Liu W, Jin G, Liu W, Liang C
and Jiang X: Discovery of novel serum biomarkers for diagnosing and
predicting postmenopausal osteoporosis patients by 4D-label free
protein omics. J Orthop Res. 41:2713–2720. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
211
|
Pico MJ, Hashemi S, Xu F, Nguyen KH,
Donnelly R, Moran E and Flowers S: Glucocorticoid receptor-mediated
cis-repression of osteogenic genes requires BRM-SWI/SNF. Bone Rep.
5:222–227. 2016. View Article : Google Scholar
|
|
212
|
Chi SN, Yi JS, Williams PM, Roy-Chowdhuri
S, Patton DR, Coffey BD, Reid JM, Piao J, Saguilig L, Alonzo TA, et
al: Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2
alterations: Results from NCI-COG pediatric MATCH APEC1621C. J Natl
Cancer Inst. 115:1355–1363. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
213
|
Martin LJ, Koegl M, Bader G, Cockcroft XL,
Fedorov O, Fiegen D, Gerstberger T, Hofmann MH, Hohmann AF, Kessler
D, et al: Structure-based design of an in vivo active selective
BRD9 inhibitor. J Med Chem. 59:4462–4475. 2016. View Article : Google Scholar : PubMed/NCBI
|
